174 related articles for article (PubMed ID: 3033468)
21. Antiviral activity of oxetanocins against varicella-zoster virus.
Sakuma T; Saijo M; Suzutani T; Yoshida I; Saito S; Kitagawa M; Hasegawa S; Azuma M
Antimicrob Agents Chemother; 1991 Jul; 35(7):1512-4. PubMed ID: 1656865
[TBL] [Abstract][Full Text] [Related]
22. (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU).
De Clercq E
Med Res Rev; 2005 Jan; 25(1):1-20. PubMed ID: 15389733
[TBL] [Abstract][Full Text] [Related]
23. Highly purified recombinant varicella Zoster virus thymidine kinase is a homodimer.
Amrhein I; Wurth C; Bohner T; Hofbauer R; Folkers G; Scapozza L
Protein Expr Purif; 2000 Apr; 18(3):338-45. PubMed ID: 10733888
[TBL] [Abstract][Full Text] [Related]
24. Comparative cytostatic activity of different antiherpetic drugs against herpes simplex virus thymidine kinase gene-transfected tumor cells.
Balzarini J; Bohman C; Walker RT; de Clercq E
Mol Pharmacol; 1994 Jun; 45(6):1253-8. PubMed ID: 8022417
[TBL] [Abstract][Full Text] [Related]
25. Immunochemical characterization of pyrimidine kinase induced by varicella-zoster virus.
Shiraki K; Ogino T; Yamanishi K; Takahashi M
J Gen Virol; 1985 Feb; 66 ( Pt 2)():221-9. PubMed ID: 2981965
[TBL] [Abstract][Full Text] [Related]
26. Incorporation of E-5-(2-halovinyl)-2'-deoxyuridines into deoxyribonucleic acids of herpes simplex virus type 1-infected cells.
Allaudeen HS; Chen MS; Lee JJ; De Clercq E; Prusoff WH
J Biol Chem; 1982 Jan; 257(2):603-6. PubMed ID: 6274855
[TBL] [Abstract][Full Text] [Related]
27. Varicella-zoster virus thymidine kinase gene and antiherpetic pyrimidine nucleoside analogues in a combined gene/chemotherapy treatment for cancer.
Degrève B; Andrei G; Izquierdo M; Piette J; Morin K; Knaus EE; Wiebe LI; Basrah I; Walker RT; De Clercq E; Balzarini J
Gene Ther; 1997 Oct; 4(10):1107-14. PubMed ID: 9415318
[TBL] [Abstract][Full Text] [Related]
28. 5-alkynyl analogs of arabinouridine and 2'-deoxyuridine: cytostatic activity against herpes simplex virus and varicella-zoster thymidine kinase gene-transfected cells.
Cristofoli WA; Wiebe LI; De Clercq E; Andrei G; Snoeck R; Balzarini J; Knaus EE
J Med Chem; 2007 Jun; 50(12):2851-7. PubMed ID: 17518459
[TBL] [Abstract][Full Text] [Related]
29. Differential phosphorylation of (E)-5-(2-bromovinyl)-2'-deoxyuridine monophosphate by thymidylate kinases from herpes simplex viruses types 1 and 2 and varicella zoster virus.
Fyfe JA
Mol Pharmacol; 1982 Mar; 21(2):432-7. PubMed ID: 6285172
[TBL] [Abstract][Full Text] [Related]
30. Intracellular uptake of thymidine and antiherpetic drugs for thymidine kinase-deficient mutants of herpes simplex virus type 1.
Bae PK; Kim JH; Kim HS; Chung IK; Paik SG; Lee CK
Antiviral Res; 2006 Jul; 70(3):93-104. PubMed ID: 16546268
[TBL] [Abstract][Full Text] [Related]
31. Specific recognition of the bicyclic pyrimidine nucleoside analogs, a new class of highly potent and selective inhibitors of varicella-zoster virus (VZV), by the VZV-encoded thymidine kinase.
Sienaert R; Naesens L; Brancale A; De Clercq E; McGuigan C; Balzarini J
Mol Pharmacol; 2002 Feb; 61(2):249-54. PubMed ID: 11809847
[TBL] [Abstract][Full Text] [Related]
32. Effect of 5-iodo-5'-amino-2',5'-dideoxyuridine on varicella-zoster virus in vitro.
Iltis JP; Lin TS; Prusoff WH; Rapp F
Antimicrob Agents Chemother; 1979 Jul; 16(1):92-7. PubMed ID: 224809
[TBL] [Abstract][Full Text] [Related]
33. Effect of (E)-5-(2-bromovinyl)-2'-deoxyuridine on replication of Epstein-Barr virus in human lymphoblastoid cell lines.
Lin JC; Smith MC; Choi EI; De Clercq E; Verbruggen A; Pagano JS
Antiviral Res; 1985; Suppl 1():121-6. PubMed ID: 3002251
[TBL] [Abstract][Full Text] [Related]
34. Murine mammary FM3A carcinoma cells transformed with the herpes simplex virus type 1 thymidine kinase gene are highly sensitive to the growth-inhibitory properties of (E)-5-(2-bromovinyl)-2'-deoxyuridine and related compounds.
Balzarini J; de Clercq E; Ayusawa D; Seno T
FEBS Lett; 1985 Jun; 185(1):95-100. PubMed ID: 2987041
[TBL] [Abstract][Full Text] [Related]
35. Effect of ara-T on the replication of herpes simplex virus, varicella-zoster virus and cytomegalovirus.
Miller RL; Iltis JP; Rapp F
IARC Sci Publ (1971); 1978; (24 Pt 2):991-7. PubMed ID: 221418
[TBL] [Abstract][Full Text] [Related]
36. The study of human myeloid differentiation using bromodeoxyuridine (BrdU).
Keoffler HP; Yen J; Carlson J
J Cell Physiol; 1983 Jul; 116(1):111-7. PubMed ID: 6574132
[TBL] [Abstract][Full Text] [Related]
37. Analysis of nucleotide sequence variations in herpes simplex virus types 1 and 2, and varicella-zoster virus.
Chiba A; Suzutani T; Saijo M; Koyano S; Azuma M
Acta Virol; 1998 Dec; 42(6):401-7. PubMed ID: 10358747
[TBL] [Abstract][Full Text] [Related]
38. 5-Iodo-2'-deoxy-L-uridine and (E)-5-(2-bromovinyl)-2'-deoxy-L-uridine: selective phosphorylation by herpes simplex virus type 1 thymidine kinase, antiherpetic activity, and cytotoxicity studies.
Spadari S; Ciarrocchi G; Focher F; Verri A; Maga G; Arcamone F; Iafrate E; Manzini S; Garbesi A; Tondelli L
Mol Pharmacol; 1995 Jun; 47(6):1231-8. PubMed ID: 7603465
[TBL] [Abstract][Full Text] [Related]
39. Comparison of thymidine kinase activities indiced in cells productively infected with herpesvirus saimiri and herpes simplex virus.
Honess RW; O'Hare P; Young D
J Gen Virol; 1982 Feb; 58(Pt 2):237-49. PubMed ID: 6278057
[TBL] [Abstract][Full Text] [Related]
40. (E)-5-(2-bromovinyl)-2'-deoxyuridine potentiates ganciclovir-mediated cytotoxicity on herpes simplex virus-thymidine kinase--expressing cells.
Hamel W; Zirkel D; Mehdorn HM; Westphal M; Israel MA
Cancer Gene Ther; 2001 May; 8(5):388-96. PubMed ID: 11477459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
